CoChat

DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION

Fava, Maurizio, Davidson, Katharine G. · 1996 · Psychiatric Clinics of North America

The DOI matches its Crossref record; 105 of the 107 references it cites were found in a registry or an index.

Abstract

Our results suggest that between 29% and 46% of depressed patients fail to respond fully with antidepressant treatment of adequate dose and duration. In particular, although partial response appears to occur in 12% to 15% of the depressed patients studied, nonresponse is observed in 19% to 34% of this population. The prevalence of treatment-resistant depression derived from studies using ITT analysis is likely to be an overestimate of the actual occurrence of the phenomenon, as these rates also reflect the outcome of patients who were treated inadequately or were intolerant to the treatment. On the other hand, data derived from studies using completer analysis are likely to generate under-estimates of the prevalence of this phenomenon, as patients may have dropped out before completion of the study due to lack of efficacy. One could, therefore, guess that the actual rates of treatment resistance in the clinical population of depressed patients probably lie between these two types of estimates. From an epidemiologic point of view, because the prevalence of depression has been estimated to vary from 2.6% to 5.5% in men and from 6.0% to 11.8% in women, one must conclude that treatment-resistant depression is a very common clinical problem that is likely to affect more than one third of depressed patients. In summary, treatment-resistant depression patients can be defined as those who fail to respond to standard doses (i.e., significantly superior to placebo in double-blind studies) of antidepressants administered continuously for at least 6 weeks. Additional requirements of this operational definition are an accurate diagnosis of depressive disorder, patient compliance with the treatment, the use of valid outcome measures, and therapeutic range of antidepressant blood levels for the tricyclic antidepressants. Finally, symptomatic improvement that is equal or greater than 25% and less than 50% qualifies as partial response, and less than 25% symptomatic improvement is complete nonresponse.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0193-953x(05)70283-5

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 105 references

Research works printed but not linked: 2

  1. Fava M, Kaji J, Davidson K: Clinical strategies for treatment resistant unipolar depression. In Pollack M, Rosenbaum J (eds): Clinical Challenges in Psychiatric Medicine. New York, Guilford Publications, in press
  2. Ferguson, 1994, Dothiepin versus doxepin in major depression: Results of a multicenter, placebo-controlled trial, J Clin Psychiatry, 55, 258

Cited by

See all 889

Metadata

Authors
Fava, M., & Davidson, K. G.
Venue
Psychiatric Clinics of North America
Publisher
Elsevier BV
Published
1996-06
Volume
19
Issue
2
Pages
179-200
ISSN
0193-953X (ISSN-L)
OpenAlex
W1966424565
Cited by
797
References
107
Citations by year
2026: 12 · 2025: 23 · 2024: 33 · 2023: 40 · 2022: 37 · 2021: 31 · 2020: 23 · 2019: 32 · 2018: 29 · 2017: 24 · 2016: 34 · 2015: 39 · 2014: 35 · 2013: 31 · 2012: 40
FWCI
0.95
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Psychiatric Clinics of North America (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
Keywords
treatment-resistant depression, antidepressant response, treatment failure, medication adherence, plasma drug concentration, tricyclic antidepressants, major depressive disorder, psychiatric comorbidity, psychosocial stressors, remission, functional outcome, mood disorders
MeSH terms
Antidepressive Agents, Chronic Disease, Clinical Trials as Topic, Depressive Disorder, Double-Blind Method, Drug Resistance, Female, Humans, Male, Prospective Studies, Surveys and Questionnaires, Recurrence, Retrospective Studies, Risk Factors, Comorbidity, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION. https://app.cochat.ai/papers/10.1016/s0193-953x(05)70283-5
The paper
Fava, M., & Davidson, K. G. (1996). DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION. Psychiatric Clinics of North America. https://doi.org/10.1016/s0193-953x(05)70283-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.